Ecolab (ECL)
Materials · Specialty Chemicals / Industrial Services · NYSE
A global leader in water, hygiene, and infection prevention services that helps businesses optimize their water and energy usage while ensuring public health and safety.
What Ecolab does
Ecolab is a global provider of water, hygiene, and infection prevention solutions and services. The company operates through a portfolio of segments, including Global Water, Global Institutional & Specialty, Global Life Sciences, and Global Pest Elimination, to provide cleaning, sanitizing, and water treatment products and equipment to a wide range of commercial and industrial customers.
Themes: water treatment, industrial hygiene, food safety, infection prevention, ESG / sustainability, pest control
Fundamentals
- Price$281.63 as of 2026-08-21 close
- Market cap$78.9B as of 2026-08-21
- 1-year return-0.5% 2025-08-21 close $283.06 → 2026-08-21 close $281.63
- P/E36.76 as of 2026-08-24
- Net margin+12.6% as of 2026-08-24
- Gross margin+44.2% as of 2026-08-24
- ROE+21.4% as of 2026-08-24
- Debt / equity1.31 as of 2026-08-24
- Revenue growth (YoY)+7.1% as of 2026-08-24
- Revenue CAGR (3y)+4.3% SEC XBRL
- Beta0.88 as of 2026-08-24
- Last reported earnings2026-07-28 SEC EDGAR Form 8-K (Item 2.02)
Dividend: yield +1.1%; at least 5 years of non-decreasing per-share dividends (SEC XBRL) — we do not hold the year before it, so the real streak may be longer.
How ECL compares in its sector
- price-to-earnings ratiomiddle range 94 covered Materials peers, as of 2026-08-24
- net profit margintop 25% 142 covered Materials peers, as of 2026-08-24
- operating margintop 25% 142 covered Materials peers, as of 2026-08-24
- gross margintop 25% 141 covered Materials peers, as of 2026-08-24
- return on equitytop 25% 151 covered Materials peers, as of 2026-08-24
- 3-year revenue CAGRmiddle range 127 covered Materials peers
- indicated dividend yieldbottom 25% 95 covered Materials peers, as of 2026-08-24
- free cash flow (absolute dollars, latest fiscal year)top 10% 124 covered Materials peers, as of FY2025
Position among covered Materials companies that report each metric (minimum 5 peers). A relative position within our covered catalog — not a valuation, quality, or investment judgment. A higher percentile is simply a higher value (for P/E, more expensive on earnings — never "better"). Informational only.
Top 10 scores & list membership
ECL is not currently in any published Top 10 list. Its scores are below.
Long-term score
47.2 #608 of 987 scored · #26 of 66 in Materials
Capital return 71st (consecutive years of dividend increases 5 years) and profitability 61st (return on equity 21.4%, operating margin 16.9%); weakest is valuation (22nd, price to book 7.9, price to earnings 37.8).
Short-term score
62.4 #116 of 1,704 scored · #3 of 83 in Materials
Catalysts 77th: the analyst consensus rating has improved toward "buy" since the prior reading; volume and participation 74th: trading volume is running unusually high — about 2.0× its 30-day average, a sign of heightened interest; weakest is momentum 52nd: MACD momentum is negative.
Scores as of 21 Aug 2026. Each bar is a percentile: how this company ranked against every company the score ranked, 0–100. A list is a published formula and its output, not a recommendation. Method version 2.
Dividend coverage (FY2025)
Covered by reported results. In FY2025, ECL's dividend was covered by reported results (earnings payout 36%, free-cash-flow payout 40%). This describes past coverage, not a forecast.
- Earnings payout36% dividends / net income
- Free-cash-flow payout40% dividends / (operating cash flow − capex)
Coverage derived from reported SEC EDGAR XBRL figures for FY2025 (dividends paid vs. net income and free cash flow, same fiscal year). This describes PAST coverage for one fiscal year — it does not predict whether a dividend will be maintained, raised, or cut, and a one-year payout ratio can be distorted by non-recurring items. Informational only — not financial advice.
How Ecolab looks technically
Ecolab (ECL) is trading 3.7% above its 200-day average, the long-term trend line — a longer-term uptrend. Its 50-day average crossed above its 200-day average about 10 trading days ago — a "golden cross", a bullish long-term signal. There is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 19, below the 25 that marks a real trend). Momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 54, neither overbought (above 70) nor oversold (below 30). MACD, a trend-momentum gauge, turned bearish about 7 trading days ago (its momentum flipped negative). It made a new 20-day high about 3 trading days ago. Day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 1% of the past ~6 months), which often precedes a bigger move. Trading volume is running unusually high — about 2.0× its 30-day average, a sign of heightened interest.
Trend
9
| Distance from the 200-day | it is trading 3.7% above its 200-day average, the long-term trend line — a longer-term uptrend | +3.7% |
|---|---|---|
| 50-day moving average | its average price over the last 50 trading days — a short-term trend line — is $275.86 | $275.86 |
| 200-day moving average | its average price over the last 200 trading days — the long-term trend line — is $271.48 | $271.48 |
| Swing structure | each recent peak has been higher than the one before it and each dip has been shallower — the pattern chart-watchers call an uptrend, which describes where price has already been and not where it goes next | higher highs and higher lows |
| Last swing turn | its last significant turn was a swing high 15 calendar days ago — the swings before that are what the structure reading is measured on | 15 sessions |
| Wave structure | its recent swings can be read as a completed three-part upward correction — a pullback in the A-B-C shape Elliott-wave chartists use; the labelling fails if price closes above 288.445. It is the only labelling that fits, and it describes the swings already printed, not what comes next. | possible three-wave upward correction, complete |
| Since the 50/200 cross | its 50-day average crossed above its 200-day average about 10 trading days ago — a "golden cross", a bullish long-term signal | 10 sessions |
| Above the 200-day after a dip | it recently dipped to its 200-day average (the long-term trend line) and has since climbed back above it — now about 3.7% above | +3.7% |
| Trend strength (14-day ADX) | there is no clear trend right now — the price is choppy (ADX, a 0–100 trend-strength gauge, is 19, below the 25 that marks a real trend) | 19.3 |
Momentum
3
| 14-day RSI | momentum is neutral — its 14-day RSI (a 0–100 momentum gauge) is 54, neither overbought (above 70) nor oversold (below 30) | 54.4 |
|---|---|---|
| Position in its 14-day range | it is trading around the middle of its 14-day range ($273.33 to $288.44) — its "stochastic" reading is 55 out of 100, where 0 would mean closing exactly at the 14-session low and 100 exactly at the high. This measures WHERE the price sits inside its recent range, which is a different question from the RSI beside it: RSI is a momentum gauge, measuring how FAST the price has been moving, so a stock can drift quietly to the bottom of its range with an ordinary RSI, or fall sharply and still sit in the middle. It has been slipping within that range over the last few sessions. | 54.9 |
| Since the MACD crossed zero | MACD, a trend-momentum gauge, turned bearish about 7 trading days ago (its momentum flipped negative) | 7 sessions |
Range
12
| 52-week high | its highest closing price over the past year (about 252 trading days) was $309.24 | $309.24 |
|---|---|---|
| From the 52-week high | it is 8.9% below its 52-week high (its highest price of the past year) | -8.9% |
| Above the 52-week low | it is 15.8% above its 52-week low (its lowest price of the past year) | +15.8% |
| Below the 52-week high | it is 8.9% below its highest point of the past year | 8.9% |
| Since a 20-day breakout | it made a new 20-day high about 3 trading days ago | 3 sessions |
| Since a 55-day breakout | it made a new 55-day high about 3 trading days ago | 3 sessions |
| All-time high | its highest closing price on record is $309.24 (set on 2026-02-25) | $309.24 |
| Given back of the 52-week move | over the past year its closes ranged ($245.73 to $308.35), and it has recovered a bit over half of its fall from last year’s high — 57% of it. Chart-watchers call 61.8%-65% given back the "golden pocket" — for this company that is $284.43 to $286.43. It is watched widely enough that orders cluster there, which is the honest reason it matters; it is not a forecast. | 57.3% |
| From the all-time high | it is 8.9% below its all-time high | -8.9% |
| Nearest price level | it is sitting right on a support level at $281.43 — a price it turned at three times since 2025-10-08, most recently on 2026-07-17. Since 2024-08-21 it has 7 such levels below the current price and 2 above. Levels like these describe where the price has reversed or paused before; they are not a forecast of where it will go. | -0.1% |
| All-time low | its lowest closing price on record is $7.44 (set on 1996-08-22) | $7.44 |
| Above the all-time low | it is 3686.6% above its all-time low | +3,687% |
Volatility
5
| Band width vs its own 6 months | day-to-day price swings are unusually narrow versus its own recent history — a "Bollinger squeeze" (in the tightest 1% of the past ~6 months), which often precedes a bigger move | 1st percentile |
|---|---|---|
| Typical daily range | in a typical session it travels about $5.84 between its high and its low — about 2.1% of its price. That is its "average true range" over the last 14 sessions, which also counts the distance from the previous close, so a day that opens well away from yesterday counts as the large move it was | $5.84 |
| Bollinger bands (20-day, ±2σ) | most of its recent trading has stayed between about $273.13 and $288.48 — the "Bollinger bands", a range drawn two standard deviations either side of its 20-day average price, which widens when the stock gets more volatile and narrows when it settles | $273.13 – $280.80 – $288.48 |
| Typical daily range (% of price) | its price moves about 2.1% in a typical session — calmer than most companies we cover. This is the average gap between a session's high and low over the last 14 sessions, counting overnight moves, expressed against the current price so it can be compared with companies trading at any price | 2.1% |
| Stretch from the 200-day average | it is trading 1.7 daily ranges above its 200-day average price (3.7% above it in plain percentage terms) — a way of asking how far it has stretched from its own average in units of how far it normally moves in a day, so a calm company and a jumpy one can be compared on the same scale | 1.7 daily ranges above its 200-day average |
Volume
1
| Volume vs its 30-day average | trading volume is running unusually high — about 2.0× its 30-day average, a sign of heightened interest | 2.00× |
|---|
Analyst
2
| Change in the average price target | analysts' average price target is unchanged from the prior reading | 0.0% |
|---|---|---|
| Change in the consensus rating | the analyst consensus rating has improved toward "buy" since the prior reading | 0.05 toward buy |
Candlestick patterns
1
| Since a doji | today it opened and closed at almost the same price after trading through a wider range — a "doji", the classic picture of buyers and sellers finishing the session level | today |
|---|
Price gaps
3
| Gap at the open | it opened on 2026-08-21 at essentially the same price it closed at the session before — no meaningful overnight gap | -0.1% |
|---|---|---|
| Open gap | it gapped 2.4% above the previous close 18 sessions ago and has not traded back through the level it left behind at 271.38 — an "unfilled gap", which describes a price range no trade has since crossed and is not a forecast that it will be crossed | +2.4% |
| Gap filled | a 2.3% gap up opened on 2026-05-27 has been "filled" 54 sessions ago — price traded back through the level the gap left behind, and it took 3 sessions to close | 54 sessions ago |
Price streaks
1
| Closing streak | it closed higher in its latest session, after a session that did not close higher — a single up day rather than a run | 1 session up |
|---|
Relative strength
4
| vs market, 1 month | over the past 1 month this stock beat the market by 4.3 percentage points (the stock gained 6.6% while the market gained 2.3%) | +4.3% |
|---|---|---|
| vs market, 3 months | over the past 3 months this stock beat the market by 9.5 percentage points (the stock gained 12.6% while the market gained 3.1%) | +9.5% |
| vs market, 6 months | over the past 6 months this stock lagged the market by 18.5 percentage points (the stock lost 7.4% while the market gained 11.1%) | -18.5% |
| vs market, 12 months | over the past 12 months this stock lagged the market by 21.0 percentage points (the stock lost 0.5% while the market gained 20.5%) | -21.0% |
Signal agreement
2
| Bullish technical signals | 4 of the 9 technical signals we can compute for it are currently in a bullish state: a "golden cross" — its 50-day average is above its 200-day, trading above its 200-day average, a fresh 20-day high, trading above the Ichimoku cloud — these describe past price behaviour, not a forecast | 4 of 9 |
|---|---|---|
| Bearish technical signals | 2 of the 9 technical signals we can compute for it are currently in a bearish state: MACD momentum is negative, lagging the market over 6 months — these describe past price behaviour, not a forecast | 2 of 9 |
Trend (Ichimoku cloud)
1
| Vs the Ichimoku cloud | trading 2.5% above the Ichimoku cloud — a band drawn from where its own highs and lows sat up to 2026-07-16 and projected forward over today's price, the side traders read as an established uptrend, with the band below acting as the level that would have to give way. The band itself is moderate, spanning 3.2% of the share price. | +2.5% |
|---|
Volume-weighted price
2
| Vs this year’s average price paid | the price is 3% above the average price paid so far this year, so the typical buyer over that stretch is showing a gain. That average is $273.29 — a volume-weighted average of daily closes over 157 sessions, not a true tick-by-tick VWAP. | +3.0% |
|---|---|---|
| Vs the average paid since it last reported | the price is sitting right on the average price paid since it last reported on 2026-07-28 (its 8-K), so the typical buyer over that stretch is roughly break-even. That average is $281.14 — a volume-weighted average of daily closes over 19 sessions, not a true tick-by-tick VWAP. | +0.2% |
Price levels it has turned at before
ECL last closed at $281.63 on 2026-08-21. Since 2024-08-21 it has turned at 7 prices below its last close and 2 above; the 3 nearest below and the 2 nearest above are listed, nearest first.
| Level | Side | Distance | Evidence |
|---|---|---|---|
| $281.43 | Support | 0.1% below the last close | turned there three times · 2025-10-08 to 2026-07-17 |
| $276.38 | Support | 1.9% below the last close | turned there five times · 2025-03-03 to 2026-04-17 |
| $288.37 | Resistance | 2.4% above the last close | turned there twice · 2026-07-07 to 2026-08-06 |
| $268.52 | Support | 4.7% below the last close | turned there 7 times · 2025-02-14 to 2026-05-27 |
| $307.88 | Resistance | 9.3% above the last close | turned there twice · 2026-02-12 to 2026-02-25 |
A level is a price this company reversed or paused at more than once — they describe past behaviour, not a forecast of where the price will go.
Wave structure
Its recent swings can be read as a three-part upward correction — the A-B-C shape chartists use for a pullback — now complete.
This labelling fails — stops being a possible reading at all — if it closes above $288.44.
It is the only labelling that fits these swings, though its proportions are not the textbook ones.
This labelling was already in place when we began recording count changes on 2026-08-13, so how long it has stood is not something we can say yet.
Read from daily closes as of 2026-08-21.
An Elliott-wave count describes the swings already printed and the level that would disprove it. It is not a forecast, a target, or advice.
Screens: Trading above the 200-day moving average · Recent golden cross (50-day crossed above 200-day) · Tested and reclaimed 200-day support · Unusually heavy trading volume · Broke out to a new 20-day high · Broke out to a new 20-day high on heavy volume | Learn: moving average · golden cross · adx · rsi · macd · breakout · bollinger bands · volume and relative volume
Based on daily closing prices as of 2026-08-21. Describes past price behavior only — informational, not financial advice.
Analyst consensus
- Consensus ratingBuy (1.60 mean, 1=Strong Buy…5=Strong Sell) — 21 analysts
- Mean price target$324.67 range $295.00 – $360.00; median $330.00
Analyst estimates, as of 2026-08-19. These are third-party analyst opinions and price targets, aggregated — not a recommendation, prediction, or advice from stocks-llm. Informational only.
Analyst EPS estimate for ECL
- Consensus EPS estimate$2.18 next reporting period, as of 2026-08-19
Change over time is not available yet: it needs two readings of the same reporting period at least 30 days apart, and we have been recording these estimates since 2026-08-04. An estimate for a DIFFERENT quarter is not a revision, so a reading from before the last report is never compared with one after it.
The consensus estimate for the next reporting period, and how it has moved between readings of that SAME period. A change is measured only between readings estimating one period — when a company reports, the consensus moves to the next quarter and the two numbers are not comparable. Informational only, not a forecast and not advice.
Key risks (from latest filing)
["Fluctuations in foreign currency exchange rates","Potential volatility in raw material and energy costs","Ability to integrate acquisitions and realize expected synergies"]
What changed in the latest 10-Q
AI-assisted comparison of ECL's 10-Q filed 2026-05-07 against the prior one filed 2025-10-30.
Management's Discussion & Analysis (MD&A)
- Added:
- Newer filing (2026-05-07) references Annual Report on Form 10-K for year ended December 31, 2025, whereas older filing (2025-10-30) references Form 10-K for year ended December 31, 2024
- Newer filing describes reorganization effective January 1, 2026, splitting Light & Heavy segment into three segments (Heavy Water, Light Water, High-Tech), resulting in nine operating segments
- Newer filing reports Q1 2026 results: reported net sales increased 10% to $4,066.1 million, organic sales increased 4%
- Newer filing states Global Water organic sales increased 2% to $1,940.2 million with double-digit growth in High-Tech
- Newer filing reports Global Institutional & Specialty organic sales increased 4% to $1,507.7 million
- Newer filing reports Global Pest Elimination organic sales increased 7% to $308.5 million
- Newer filing reports Global Life Sciences organic sales increased 11% to $200.9 million
- Newer filing shows Q1 2026 reported operating income increased 12% to $622.0 million with adjusted operating income up 15%
- Newer filing shows Q1 2026 net income attributable to Ecolab increased 7% to $432.6 million
- Newer filing shows Q1 2026 reported diluted EPS increased 8% to $1.52 and adjusted diluted EPS increased 13% to $1.70
- Newer filing shows Q1 2026 reported tax rate 21.8% vs 20.3% prior year, adjusted tax rate 21.0% vs 20.8%
- Newer filing includes Q1 2026 net sales breakdown: product and equipment $3,174.6 million, service and lease $891.5 million
- Removed:
- Older filing (2025-10-30) references reorganization effective January 1, 2025, with seven operating segments including Light & Heavy segment
- Older filing contains reference to ChampionX separation from 2020 and related product sales transactions, which is not mentioned in newer filing
- Older filing reports Q3 2025 results: reported net sales increased 4% to $4,165.0 million, organic sales increased 3%
- Older filing states Global Water organic sales increased 2% to $1,929.4 million
- Older filing reports Global Institutional & Specialty organic sales increased 4% to $1,544.4 million
- Older filing reports Global Pest Elimination organic sales increased 6% to $321.3 million
- Older filing reports Global Life Sciences organic sales increased 6% to $171.0 million
- Older filing shows Q3 2025 reported operating income decreased 27% to $760.2 million
- Older filing shows Q3 2025 net income attributable to Ecolab decreased 21% to $585.0 million
- Older filing shows Q3 2025 reported diluted EPS decreased 21% to $2.05 and adjusted diluted EPS increased 13% to $2.07
- Older filing shows Q3 2025 reported tax rate 17.8% vs 25.0% prior year, adjusted tax rate 20.0% vs 19.7%
- Older filing includes nine-month period data (September 30)
- Reworded:
- Reportable Segments description updated: newer filing describes current structure with Heavy Water, Light Water, High-Tech segments effective January 1, 2026; older filing described prior structure with Light & Heavy segment effective January 1, 2025
- Quarterly period compared: newer filing compares Q1 2026 to Q1 2025; older filing compared Q3 2025 to Q3 2024
- Notes:
- The newer and older filings compare different quarters (Q1 vs Q3) in different calendar years (2026 vs 2025), reflecting normal quarterly reporting cycle differences
- Newer filing text appears truncated at the end of the Cost of Sales section; comparison is based on available text only
Risk Factors
- Added:
- Reference to Form 10-K for year ended December 31, 2025, filed February 23, 2026 (newer filing, 2026-05-07)
- Share repurchase data for January 1-31, 2026: 158,947 shares at $270.7352 average price (newer filing, 2026-05-07)
- Share repurchase data for February 1-28, 2026: 55,490 shares at $302.8313 average price (newer filing, 2026-05-07)
- Share repurchase data for March 1-31, 2026: 1,038,936 shares at $266.9159 average price (newer filing, 2026-05-07)
- Maximum shares yet to be purchased: 4,643,448 (as of March 31, 2026) (newer filing, 2026-05-07)
- Exhibit (10.1): Term Credit Agreement dated April 10, 2026 with Citibank, N.A. (newer filing, 2026-05-07)
- Exhibit (10.2): Relocation Agreement dated February 20, 2026 with Darrell R. Brown (newer filing, 2026-05-07)
- Removed:
- Reference to Form 10-K for year ended December 31, 2024, filed February 21, 2025 (older filing, 2025-10-30)
- Share repurchase data for July 1-31, 2025: - shares at $- average price (older filing, 2025-10-30)
- Share repurchase data for August 1-31, 2025: 196,731 shares at $280.1000 average price (older filing, 2025-10-30)
- Share repurchase data for September 1-30, 2025: 442,913 shares at $270.1347 average price (older filing, 2025-10-30)
- Maximum shares yet to be purchased: 7,411,629 (as of September 30, 2025) (older filing, 2025-10-30)
- Exhibit (4.1): Fourteenth Supplemental Indenture dated August 27, 2025 (older filing, 2025-10-30)
- Exhibit (4.2): Form of 5.000% Notes due 2035 (older filing, 2025-10-30)
- Reworded:
- Forward-Looking Statements page reference changed from 'page s 45 and 46' to 'page s 41 and 42' (newer filing, 2026-05-07)
- Share repurchase authorization language changed from 'repurchase all shares under these authorizations' to 'repurchase all shares under this authorization' (newer filing, 2026-05-07)
- Share repurchase authorization language changed from 'accelerated share repurchase program' to 'accelerated share repurchase programs' (newer filing, 2026-05-07)
- Notes:
- The comparison focuses on Risk Factors section and subsequent items (Items 2-6) as provided; substantive risk factor disclosure content is not materially different between the two filings
- Page numbering differences reflect different 10-Q lengths due to different reporting periods (Q1 2026 vs Q3 2025)
AI-assisted comparison of two SEC filing sections. It describes wording and theme changes only, makes no materiality, legal, or investment judgement, and is not financial advice. Informational only — not financial advice.
Insider activity (SEC Form 4)
2 open-market purchases and 3 open-market sales by insiders in the last 90 days.
- Last 30 days0 buys · 1 sell ($929755) — 1 selling insider
- Last 90 days2 buys ($2M) · 3 sells ($4M) — 2 buying, 3 selling insiders
- Last 180 days4 buys ($3M) · 3 sells ($4M) — 3 buying, 3 selling insiders
Cluster buying: 3 different insiders reported open-market purchases (SEC code P) of ECL within a 30-day window between 2026-05-13 and 2026-06-11. Disclosed Form 4 activity, not a prediction of performance or a buy signal.
Activity heuristic: net selling (a transparent product heuristic from the counts above, not a prediction or advice)
Most recent open-market transaction: 2026-07-30. As of 2026-08-24.
View full insider trading history → View SEC Form 3/4/5 filingsAsk about ECL's insider activity →
Only open-market purchases (SEC code P) and sales (code S) are counted here. Option exercises, vesting/awards, gifts, and shares withheld for taxes are excluded — they are compensation or mechanical, not open-market conviction. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan) and are not necessarily bearish; open-market buying is not a recommendation to buy. Informational only — not financial advice.
Congressional trading disclosures
U.S. House members publicly disclose their own, their spouse's, and dependent children's stock transactions under the STOCK Act. We hold 6 matched disclosures for ECL from U.S. House Clerk Periodic Transaction Report filings.
Congressional trading disclosures →Institutional ownership (13F)
6 institutional 13F filers reported holding ECL as of 2026-03-31 (quarter-end position, filed within 45 days).
- Distinct 13F filers 6
- Reported shares held 36,485,254
- Reported value $9,713,809,992
reported quarterly holdings change (2025-12-31 → 2026-03-31): 1 new, 4 increased, 1 decreased, 0 exited. Change counts cover only managers that filed 13F reports in BOTH quarters, derived between two quarter-end snapshots — not same-day trades; a single manager is never said to have "bought" or "sold".
Institutional holdings are quarter-end long positions reported on SEC Form 13F-HR, filed up to 45 days after the quarter ends — they are delayed, are not real-time trades, exclude short positions and most non-US securities, and are not investment advice. Any increase/decrease is a reported change between two quarterly snapshots, not a same-day purchase or sale. These are quarter-end snapshots from the 13F filings on SEC EDGAR, filed within 45 days — not real-time, and any change is a difference between two quarterly reports, not a same-day trade. Informational only — not financial advice.
Short interest (FINRA)
ECL had 3,096,775 shares of reported short interest as of the 2026-07-31 FINRA settlement date (delayed, bi-monthly; not real-time).
ECL had 1.10% of its shares outstanding sold short as of the 2026-07-31 FINRA settlement date (percent of FLOAT would be higher — float is not disclosed in the source). FINRA reported 2.33 days to cover at the same settlement.
- Reported short interest (shares) 3,096,775
- Short interest (% of shares outstanding) 1.10%
- Prior settlement (shares) 3,314,735
- Reported change -6.58%
- Days to cover (reported) 2.33
Reported to FINRA as of the 2026-07-31 settlement date. Short interest is reported to FINRA and published on a delayed, bi-monthly schedule (as of a settlement date, disseminated roughly eight business days later) — it is NOT real-time, does not cover every venue or all US trading, and is not a short-squeeze prediction or investment advice. Days-to-cover is the value FINRA reports; percent of float is not shown because the source file carries no share-count denominator — where a percent appears it is of shares OUTSTANDING, the larger base, and is therefore a floor on percent of float. Informational only — not financial advice.
Competitors & peers
- DuPont (DD)
- Solenis
- Diversey (acquired by Solenis)
- BASF (BASFY)
- 3M (MMM)
- Rentokil Initial
AI-enriched competitor set. Linked names are companies covered by stocks-llm; other named peers are shown for reference only.
Compare ECL vs…
Ecolab is found in…
ECL shows up in…
Frequently asked questions
What does Ecolab (ECL) do?
Ecolab is a global provider of water, hygiene, and infection prevention solutions and services. The company operates through a portfolio of segments, including Global Water, Global Institutional & Specialty, Global Life Sciences, and Global Pest Elimination, to provide cleaning, sanitizing, and water treatment products and equipment to a wide range of commercial and industrial customers.
What sector is Ecolab (ECL) in?
Ecolab (ECL) is classified in the Materials sector. Its industry is Specialty Chemicals / Industrial Services. It trades on NYSE.
Does ECL pay a dividend?
Yes — Ecolab (ECL) pays a dividend, with an indicated yield of about 1.13% and at least 5 years of non-decreasing per-share dividends (SEC EDGAR XBRL) — we do not hold the year before it, so the real streak may be longer (market data, as of 2026-08-24). Informational only — not financial advice.
Who are Ecolab's (ECL) competitors?
Notable peers of Ecolab (ECL) include DuPont, Solenis, Diversey (acquired by Solenis), BASF and 3M. This peer set is informational only — not financial advice.
Has there been recent Congressional stock trading in ECL?
Yes — we hold 6 matched STOCK Act disclosures for ECL from U.S. House Clerk Periodic Transaction Report filings. These are legally-required disclosures (often filed 30–45 days after the trade), may belong to a U.S. House member, their spouse, or a dependent child, and are not an indicator of company performance or investment advice.
Is Ecolab (ECL) overbought or oversold right now?
Ecolab (ECL) is currently neither overbought nor oversold — its 14-day RSI (a 0–100 momentum gauge) is 54, in the neutral middle (as of 2026-08-21). RSI describes recent price momentum, not a forecast — informational only, not financial advice.
Where does stocks-llm's data on ECL come from?
Fundamentals and prices come from market data, as of 2026-08-24; company filings and profile facts come from SEC EDGAR. All figures are delayed daily-close data shown with their as-of date — informational only, not financial advice.
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.